https://www.biospace.com/viking-therapeutics-to-present-at-svb-securities-global-biopharma-conference
Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and...
viking therapeuticssvb securitiespresentglobalbiopharma
https://www.biospace.com/assertio-to-participate-in-the-2023-svb-securities-global-biopharma-conference
Assertio Holdings, Inc. today announced that Dan Peisert, CEO, and Paul Schwichtenberg, CFO, will host investor meetings February 15, 2023 as part of the SVB...
svb securitiesparticipateglobalbiopharma